BRPI0412923A - composição farmacêutica dispersìvel para o tratamento de mastite e de distúrbios óticos - Google Patents

composição farmacêutica dispersìvel para o tratamento de mastite e de distúrbios óticos

Info

Publication number
BRPI0412923A
BRPI0412923A BRPI0412923-7A BRPI0412923A BRPI0412923A BR PI0412923 A BRPI0412923 A BR PI0412923A BR PI0412923 A BRPI0412923 A BR PI0412923A BR PI0412923 A BRPI0412923 A BR PI0412923A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
treatment
mastitis
dispersible pharmaceutical
optical disorders
Prior art date
Application number
BRPI0412923-7A
Other languages
English (en)
Inventor
Nancy Jean Britten
Niki Ann Waldron
Jeffrey Lynn Watts
John Walter Hallberg
John Willian Ii Burns
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of BRPI0412923A publication Critical patent/BRPI0412923A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Packages (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA DISPERSìVEL PARA O TRATAMENTO DE MASTITE E DE DISTúRBIOS óTICOS". é providenciado um método para o tratamento e/ou prevenção de uma condição infecciosa em um órgão que contém fluidos, com um orifício exterior natural, tal como o úbere de um animal produtor de leite ou um ouvido de um indivíduo. A invenção refere-se igualmente a uma composição farmacêutica dispersível adequada para infusão em um órgão, de acordo com o método da invenção, e a um processo para a preparação de tal composição.
BRPI0412923-7A 2003-07-31 2004-07-19 composição farmacêutica dispersìvel para o tratamento de mastite e de distúrbios óticos BRPI0412923A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49217803P 2003-07-31 2003-07-31
PCT/IB2004/002474 WO2005009472A2 (en) 2003-07-31 2004-07-19 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Publications (1)

Publication Number Publication Date
BRPI0412923A true BRPI0412923A (pt) 2006-09-26

Family

ID=34103028

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412923-7A BRPI0412923A (pt) 2003-07-31 2004-07-19 composição farmacêutica dispersìvel para o tratamento de mastite e de distúrbios óticos

Country Status (13)

Country Link
EP (1) EP1656159A2 (pt)
JP (1) JP2007500692A (pt)
KR (1) KR100807414B1 (pt)
CN (1) CN1812814A (pt)
AU (1) AU2004258746A1 (pt)
BR (1) BRPI0412923A (pt)
CA (1) CA2529405A1 (pt)
IL (1) IL171893A0 (pt)
MX (1) MXPA06001192A (pt)
NO (1) NO20055466L (pt)
RU (1) RU2329064C2 (pt)
WO (1) WO2005009472A2 (pt)
ZA (1) ZA200600850B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012215A (es) * 2004-04-22 2007-04-19 Pfizer Prod Inc Metodo de estabilizacion de la sal sodica cefovecina desordenada.
CA2877794C (en) * 2012-06-29 2020-08-04 Bayer Animalhealth Gmbh Pharmaceutical compositions and treatment of mastitis
AU2014306781A1 (en) * 2013-08-12 2015-12-24 Merlion Pharmaceuticals, Pte., Ltd. Method for treating otic infections after tympanostomy tube placement
CN104622875B (zh) * 2015-02-12 2017-05-10 江西博莱大药厂有限公司 一种抗奶牛乳腺炎的乳房注入药剂及其制备方法
EP3370698B1 (en) * 2015-11-03 2022-01-26 Zoetis Services LLC Sol-gel polymer composites and uses thereof
RU2663070C1 (ru) * 2017-05-04 2018-08-01 Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) Способ лечения отомикоза
CN117618440A (zh) * 2024-01-15 2024-03-01 山东第一医科大学(山东省医学科学院) 一种头孢拉定一水合物在制备抗顺铂耳毒性药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190445B (it) * 1985-11-08 1988-02-16 Fatro Spa Composizioni veterinarie a base di agenti antimicrobici e loro impiego
ES2173287T3 (es) * 1995-06-06 2002-10-16 Bayer Ag Composiciones oticas antibacterianas no irritantes, no sensibilizantes y no ototoxicas.
US5910138A (en) * 1996-05-13 1999-06-08 B. Braun Medical, Inc. Flexible medical container with selectively enlargeable compartments and method for making same
RU2156131C1 (ru) * 1996-06-21 2000-09-20 Беляев Юрий Евгеньевич Полуфабрикат для получения основы лекарственного средства, основы лекарственного средства из этого полуфабриката (варианты) и лекарственное средство на этой основе (варианты)
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US20010049366A1 (en) * 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid

Also Published As

Publication number Publication date
WO2005009472A3 (en) 2005-04-07
EP1656159A2 (en) 2006-05-17
JP2007500692A (ja) 2007-01-18
KR100807414B1 (ko) 2008-02-25
NO20055466L (no) 2006-04-21
RU2006102665A (ru) 2006-06-10
MXPA06001192A (es) 2006-04-11
AU2004258746A1 (en) 2005-02-03
CA2529405A1 (en) 2005-02-03
KR20060033031A (ko) 2006-04-18
CN1812814A (zh) 2006-08-02
RU2329064C2 (ru) 2008-07-20
WO2005009472A2 (en) 2005-02-03
ZA200600850B (en) 2007-05-30
IL171893A0 (en) 2006-04-10
NO20055466D0 (no) 2005-11-18

Similar Documents

Publication Publication Date Title
BRPI0412581A (pt) formulação dispersável de um agente antiinflamatório
BRPI0408559A (pt) composições farmacêuticas dispersìveis para o tratamento de mastite e distúrbios óticos
EA200870393A1 (ru) Новые композиции для нарушений волос и способ получения композиций
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
EP1363632A4 (en) SELECTIVE CANNABIMIMETIC AMINOALKYLINDOLES OF A RECEPTOR
BR0114466B1 (pt) métodos para tratamento e prevenção de dano por uma peste a uma semente e/ou brotos e folhagem de uma planta, e comoposição para o tratamento de semente não plantada
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
BRPI0618374A2 (pt) uso de um composto ou um derivado do mesmo farmaceuticamente aceitável, métodos para matar microorganismos clinicamente latentes em um mamìfero, para tratar ou prevenir uma infecção microbiana em um mamìfero, para esterilizar um objeto, para preservar um material inorgánico ou orgánico, para tratar uma doença, para reduzir a dose de agente antimicrobiano convencional requerida para tratar uma infecção microbiana e para tratar uma doença de protozoário em um mamìfero, produto combinado, formulação, uso de um produto combinado, composto, e, processo para a preparação do mesmo
WO2008054545A3 (en) Method of inhibiting the transmission of viruses
BR0212898A (pt) Método de tratamento de infecções do ouvido médio
BR0013010B1 (pt) Formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
BR0009776A (pt) Método de tratamento
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
MX2007012794A (es) Composiciones para el tratamiento de trastornos del tejido conectivo de la piel.
BR0306855A (pt) Método para o tratamento de distúrbios cognitivos
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
BR0113461A (pt) Compostos ou sais farmaceuticamente aceitáveis, composições farmacêuticas, método de tratamento de doença ou condição mediada por erab, hadh2 ou (beta)-amilóide em mamìferos, métodos de inibição ou modulação da atividade enzimática de erab ou hadh2 e método de tratamento de mal de alzheimer ou demência em mamìferos
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
ATE437641T1 (de) Verfahren zur herstellung von medikamenten zur verringerung der amyloid-abscheidung, amyloid- neurotoxizität und mikrogliosis
BR0110845A (pt) Derivados de dissulfeto de anilina para o tratamento de doenças alérgicas
BR0309611A (pt) ácidos aminoalcanofosfÈnicos substituìdos para o tratamento da dor neuropática, dos distúrbios afetivos e da atenção, da esquizofrenia, do zumbido no ouvido, da miopia e de outros distúrbios oculares.
WO2005009472A3 (en) Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
BR9915914A (pt) Processo para a crio-conservação de plantas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.